Journal of Minimally Invasive Surgery 2019; 22(3): 89-90
Published online September 15, 2019
https://doi.org/10.7602/jmis.2019.22.3.89
© The Korean Society of Endo-Laparoscopic & Robotic Surgery
Correspondence to : Yeon Soo Chang, Department of Surgery, Eulji Medical Center, Eulji University College of Medicine, 68 Hangeulbiseok-ro, Nowon-gu, Seoul 01830, Korea, Tel: +82-2-970-8688, Fax: +82-2-970-8227, E-mail: cutdowngs@naver.com, ORCID: https://orcid.org/0000-0002-6570-5920
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
A subepithelial tumor (SET) is a common disease of the stomach. A gastrointestinal stromal tumor (GIST), which has malignant potential, is the most common tumor among SETs. The definite treatment of SETs of the stomach should be a complete resection; thus, a laparoscopic wedge resection has been the standard treatment for SET of the stomach. The surgical and oncologic outcomes of laparoscopic wedge resections for gastric GIST have shown it to be safe and feasible compared to open surgery. The authors reported that small sized SET and tumor located in areas other than the posterior wall can be a candidate for shorter hospitalization. The critical pathway (CP) and new therapeutic options can be helpful for reducing the hospital stay. On the other hand, it is important not to overlook the fatal complications after discharge.
Keywords Laparoscopy, Stomach, Gastrointestinal stromal tumor, Hospitalization
Subepithelial tumors (SETs) are a common disease of the stomach. An endoscopic biopsy for a pathological diagnosis is difficult because SETs are usually covered with normal mucosa. Gastrointestinal stromal tumors (GISTs), which have malignant potential regardless of their size, are the most common tumors among SETs of the stomach. Therefore, definite treatment of a SET of the stomach should be a complete resection. A local resection is regarded as the primary treatment because lymph node metastasis is quite rare in GIST.1
With the development of laparoscopic instruments and surgical techniques, a laparoscopic wedge resection has been the standard treatment for SET of the stomach. The surgical and oncologic outcomes of a laparoscopic wedge resection for gastric GIST have shown it to be safe and feasible compared to open surgery, even in large GIST over 5 cm in size.2,3
The advantages of laparoscopic surgery over open surgery are well known, including shorter hospitalization and rapid recovery to usual activity. The authors analyzed the factors influencing the morbidity and hospital stay after a laparoscopic resection of gastric SET. The results showed that a larger size (>5 cm) and location on the posterior wall of the stomach can prolong the hospital stay than expected. The authors report that a small sized SET and tumor located other than the posterior wall can be a candidate for shorter hospitalization. Stanek et al.3 reported similar results in that the hospital stay was longer in the larger tumor group (>5 cm). A laparoscopic resection of SET in a difficult location of the stomach is quite a challenge. An inadequate angle for the laparoscopic approach and insufficient exposure of the tumor can increase the postoperative morbidity, including leakage, bleeding, and stenosis. On the other hand, another report showed no difference in the hospital stay in different anatomical locations of gastric GIST.4
The hospital stay can be affected by not only the size and location of the tumor, but also by many other factors, including fever, pain, wound infection, oliguria, hemorrhage, and general condition of the patient. Like the results of the authors of this article, a well-configured critical pathway (CP) standardizes the various treatment protocols to reduce the variables during hospitalization and medical costs and increase patient satisfaction.
Recently, an emerging therapeutic option for gastric SET has been introduced. Laparoscopic and endoscopic cooperative surgery (LECS) as well as non-exposed endoscopic wall-inversion surgery (NEWS) have advantages for the precise localization and resection of small-sized gastric SETs, particularly in endophytic tumors.5,6 A robotic-assisted resection can be quite helpful in gastric SET in unfavorable locations in a manner that provides adequate exposure, resection, and repair with articulating instruments.7 These new options can be expected to help reduce the hospital stay.
Short-term hospitalization has many advantages, but it is important to prepare safe treatment protocols and to check all conditions of the patients before discharge so that fatal complications are not overlooked after discharge.
None.
None.
Journal of Minimally Invasive Surgery 2019; 22(3): 89-90
Published online September 15, 2019 https://doi.org/10.7602/jmis.2019.22.3.89
Copyright © The Korean Society of Endo-Laparoscopic & Robotic Surgery.
Department of Surgery, Eulji Medical Center, Eulji University College of Medicine, Seoul, Korea
Correspondence to:Yeon Soo Chang, Department of Surgery, Eulji Medical Center, Eulji University College of Medicine, 68 Hangeulbiseok-ro, Nowon-gu, Seoul 01830, Korea, Tel: +82-2-970-8688, Fax: +82-2-970-8227, E-mail: cutdowngs@naver.com, ORCID: https://orcid.org/0000-0002-6570-5920
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
A subepithelial tumor (SET) is a common disease of the stomach. A gastrointestinal stromal tumor (GIST), which has malignant potential, is the most common tumor among SETs. The definite treatment of SETs of the stomach should be a complete resection; thus, a laparoscopic wedge resection has been the standard treatment for SET of the stomach. The surgical and oncologic outcomes of laparoscopic wedge resections for gastric GIST have shown it to be safe and feasible compared to open surgery. The authors reported that small sized SET and tumor located in areas other than the posterior wall can be a candidate for shorter hospitalization. The critical pathway (CP) and new therapeutic options can be helpful for reducing the hospital stay. On the other hand, it is important not to overlook the fatal complications after discharge.
Keywords: Laparoscopy, Stomach, Gastrointestinal stromal tumor, Hospitalization
Subepithelial tumors (SETs) are a common disease of the stomach. An endoscopic biopsy for a pathological diagnosis is difficult because SETs are usually covered with normal mucosa. Gastrointestinal stromal tumors (GISTs), which have malignant potential regardless of their size, are the most common tumors among SETs of the stomach. Therefore, definite treatment of a SET of the stomach should be a complete resection. A local resection is regarded as the primary treatment because lymph node metastasis is quite rare in GIST.1
With the development of laparoscopic instruments and surgical techniques, a laparoscopic wedge resection has been the standard treatment for SET of the stomach. The surgical and oncologic outcomes of a laparoscopic wedge resection for gastric GIST have shown it to be safe and feasible compared to open surgery, even in large GIST over 5 cm in size.2,3
The advantages of laparoscopic surgery over open surgery are well known, including shorter hospitalization and rapid recovery to usual activity. The authors analyzed the factors influencing the morbidity and hospital stay after a laparoscopic resection of gastric SET. The results showed that a larger size (>5 cm) and location on the posterior wall of the stomach can prolong the hospital stay than expected. The authors report that a small sized SET and tumor located other than the posterior wall can be a candidate for shorter hospitalization. Stanek et al.3 reported similar results in that the hospital stay was longer in the larger tumor group (>5 cm). A laparoscopic resection of SET in a difficult location of the stomach is quite a challenge. An inadequate angle for the laparoscopic approach and insufficient exposure of the tumor can increase the postoperative morbidity, including leakage, bleeding, and stenosis. On the other hand, another report showed no difference in the hospital stay in different anatomical locations of gastric GIST.4
The hospital stay can be affected by not only the size and location of the tumor, but also by many other factors, including fever, pain, wound infection, oliguria, hemorrhage, and general condition of the patient. Like the results of the authors of this article, a well-configured critical pathway (CP) standardizes the various treatment protocols to reduce the variables during hospitalization and medical costs and increase patient satisfaction.
Recently, an emerging therapeutic option for gastric SET has been introduced. Laparoscopic and endoscopic cooperative surgery (LECS) as well as non-exposed endoscopic wall-inversion surgery (NEWS) have advantages for the precise localization and resection of small-sized gastric SETs, particularly in endophytic tumors.5,6 A robotic-assisted resection can be quite helpful in gastric SET in unfavorable locations in a manner that provides adequate exposure, resection, and repair with articulating instruments.7 These new options can be expected to help reduce the hospital stay.
Short-term hospitalization has many advantages, but it is important to prepare safe treatment protocols and to check all conditions of the patients before discharge so that fatal complications are not overlooked after discharge.
None.
None.
None.
In-Kyeong Kim, M.D., Ji-Ho Park, M.D., Young-Joon Lee, M.D., Ph.D., Sang-Ho Jeong, M.D., Ph.D., Tae Han Kim, M.D., Ph.D., Dong-Hwan Kim, M.D., Han-Gil Kim, M.D., Jin-Kyu Cho, M.D., Jae-Myung Kim, M.D., Seung-Jin Kwag, M.D., Ph.D., Ju-Yeon Kim, M.D., Ph.D., Chi-Young Jeong, M.D., Ph.D., Young-tae Ju, M.D., Ph.D., Eun-Jung Jung, M.D., Ph.D., Soon-Chan Hong, M.D., Ph.D.
Journal of Minimally Invasive Surgery 2020; 23(4): 172-178Chang In Choi, M.D., Dae Hwan Kim, M.D., Si Hak Lee, M.D., Jae Hun Kim, M.D., Sun Hwi Hwang, M.D., Tae Yong Jeon, M.D., Hae Young Kim, M.D., Dong Heon Kim, M.D., Gwang Ha Kim, M.D., Do Yoon Park, M.D.
J Minim Invasive Surg 2010; 13(1): 6-10Kwang Hyun Kim, Eui Hyuk Chong, Incheon Kang, Sung Hwan Lee, Seok Jeong Yang
Journal of Minimally Invasive Surgery 2024; 27(2): 118-124